- Home
- IART
as 11-15-2024 3:36pm EST
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | 1.3B | IPO Year: | 1995 |
| Target Price: | $30.88 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Hold | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.81 - $45.42 | Next Earning Date: | 11-04-2024 |
| Revenue: | $1,564,920,000 | Revenue Growth: | 1.45% |
| Revenue Growth (this year): | 6.71% | Revenue Growth (next year): | 6.08% |
Stock Insider Trading Activity of Integra LifeSciences Holdings Corporation (IART)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mosebrook Jeffrey | IART | SVP, Fin & Princ Acct Officer | Aug 19 '24 | Sell | $21.58 | 1,191 | $25,700.83 | 36,088 |
Latest Integra LifeSciences Holdings Corporation News
IART Breaking Stock News: Dive into IART Ticker-Specific Updates for Smart Investing
Argus Research
2 days ago
Analyst Report: Integra Lifesciences Hldgs Cor
Argus Research
2 days ago
Market Update: AMAT, BA, DIS, IART, SBUX, ABNB
Zacks
3 days ago
IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant
GlobeNewswire
4 days ago
Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
TipRanks
11 days ago
Integra LifeSciences price target raised to $22 from $16 at Citi
MT Newswires
12 days ago
Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating
Zacks
12 days ago
Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure
Simply Wall St.
12 days ago
Integra LifeSciences Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Compare IART vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IART Integra LifeSciences Holdings Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.